Susan Wojcicki Acquires 1,100 Shares of salesforce.com, inc. (NYSE:CRM) Stock

Share on StockTwits

salesforce.com, inc. (NYSE:CRM) Director Susan Wojcicki bought 1,100 shares of the firm’s stock in a transaction dated Tuesday, March 24th. The shares were acquired at an average price of $150.42 per share, for a total transaction of $165,462.00. Following the transaction, the director now directly owns 103,283 shares in the company, valued at $15,535,828.86. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Susan Wojcicki also recently made the following trade(s):

  • On Wednesday, February 12th, Susan Wojcicki bought 1,100 shares of salesforce.com stock. The shares were acquired at an average price of $189.36 per share, for a total transaction of $208,296.00.
  • On Tuesday, January 7th, Susan Wojcicki acquired 1,100 shares of salesforce.com stock. The stock was purchased at an average price of $175.26 per share, for a total transaction of $192,786.00.

Shares of NYSE:CRM opened at $154.73 on Friday. The business has a 50-day moving average price of $168.92 and a 200 day moving average price of $163.34. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $137.51 billion, a price-to-earnings ratio of 773.69, a PEG ratio of 6.53 and a beta of 1.07. salesforce.com, inc. has a 12-month low of $115.29 and a 12-month high of $195.72.

salesforce.com (NYSE:CRM) last issued its quarterly earnings data on Tuesday, February 25th. The CRM provider reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.56 by $0.10. The firm had revenue of $4.85 billion during the quarter, compared to the consensus estimate of $4.75 billion. salesforce.com had a return on equity of 3.61% and a net margin of 0.74%. During the same period last year, the company earned $0.70 EPS. As a group, equities research analysts predict that salesforce.com, inc. will post 1.28 earnings per share for the current fiscal year.

A number of brokerages have weighed in on CRM. Stifel Nicolaus raised their price objective on salesforce.com from $195.00 to $210.00 and gave the company a “buy” rating in a report on Friday, February 21st. BMO Capital Markets raised their price objective on salesforce.com to $220.00 and gave the company an “outperform” rating in a report on Friday, February 21st. Sanford C. Bernstein restated a “neutral” rating and issued a $180.00 price objective on shares of salesforce.com in a report on Wednesday, February 26th. Cross Research restated an “outperform” rating on shares of salesforce.com in a report on Thursday, December 5th. Finally, UBS Group raised their price objective on salesforce.com from $190.00 to $230.00 and gave the company a “buy” rating in a report on Friday, February 21st. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a hold rating, forty have issued a buy rating and three have given a strong buy rating to the company. salesforce.com presently has an average rating of “Buy” and a consensus target price of $199.82.

Several large investors have recently modified their holdings of CRM. Assetmark Inc. grew its position in salesforce.com by 21.0% in the 4th quarter. Assetmark Inc. now owns 328 shares of the CRM provider’s stock valued at $53,000 after acquiring an additional 57 shares in the last quarter. Blackhawk Capital Partners LLC. grew its position in salesforce.com by 0.4% in the 4th quarter. Blackhawk Capital Partners LLC. now owns 14,747 shares of the CRM provider’s stock valued at $2,189,000 after acquiring an additional 58 shares in the last quarter. Earnest Partners LLC grew its position in salesforce.com by 17.0% in the 4th quarter. Earnest Partners LLC now owns 419 shares of the CRM provider’s stock valued at $68,000 after acquiring an additional 61 shares in the last quarter. Ballentine Partners LLC grew its position in salesforce.com by 0.7% in the 4th quarter. Ballentine Partners LLC now owns 9,098 shares of the CRM provider’s stock valued at $1,480,000 after acquiring an additional 64 shares in the last quarter. Finally, Highland Private Wealth Management grew its position in salesforce.com by 2.5% in the 4th quarter. Highland Private Wealth Management now owns 2,650 shares of the CRM provider’s stock valued at $431,000 after acquiring an additional 65 shares in the last quarter. 82.25% of the stock is owned by hedge funds and other institutional investors.

About salesforce.com

salesforce.com, inc. develops enterprise cloud computing solutions with a focus on customer relationship management. The company offers Sales Cloud to store data, monitor leads and progress, forecast opportunities, and gain insights through analytics and relationship intelligence, as well as deliver quotes, contracts, and invoices.

Recommended Story: How to build a Fibonacci channel

Insider Buying and Selling by Quarter for salesforce.com (NYSE:CRM)

Receive News & Ratings for salesforce.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for salesforce.com and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zacks Investment Research Downgrades Daimler  to Sell
Zacks Investment Research Downgrades Daimler to Sell
EDP-Energias de Portugal, S.A  Rating Lowered to Sell at Zacks Investment Research
EDP-Energias de Portugal, S.A Rating Lowered to Sell at Zacks Investment Research
Farmers & Merchants Bancorp, Inc.   Rating Increased to Hold at Zacks Investment Research
Farmers & Merchants Bancorp, Inc. Rating Increased to Hold at Zacks Investment Research
Zacks Investment Research Downgrades Equity BancShares  to Sell
Zacks Investment Research Downgrades Equity BancShares to Sell
Zacks Investment Research Downgrades Fiat Chrysler Automobiles  to Sell
Zacks Investment Research Downgrades Fiat Chrysler Automobiles to Sell
Verra Mobility  versus Its Peers Head to Head Analysis
Verra Mobility versus Its Peers Head to Head Analysis


 
© 2006-2020 Zolmax.